StrainX Bioworks
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
StrainX Bioworks - overview
Established
2023
Location
Bhopal, -, India
Primary Industry
Biotechnology
About
Based in India, StrainX Bioworks is a biotechnology firm focused on developing sustainable biomolecules through precision fermentation, serving diverse sectors including food, nutraceutical, and beauty industries. StrainX Bioworks specializes in the creation of high-value biomolecules using engineered microorganisms. Founded in 2023 in Bhopal, India, the company recently secured funding in a Series A round amounting to USD 13. 00 mn, co-led by Prime Venture Partners and Leo Capital, with additional support from Good Startup, Sparrow Capital, SUNiCON, IIT Delhi Endowment Fund, and Dholakia Ventures.
The latest funding will support ongoing operations and expansion. The founder's prior history includes founding other enterprises, though specific details were not disclosed. StrainX has engaged in one investment deal as of May 25, 2026. StrainX specializes in the development of sustainable, high-value biomolecules through its precision fermentation platform, transforming engineered microorganisms into functional ingredients for the food, nutraceutical, and beauty sectors.
Their core offerings include clean-label functional ingredients, health-promoting compounds, and innovative actives for skincare applications, catering to global beverage brands and consumer goods companies across North America, Europe, and Asia. StrainX generates revenue through B2B partnerships and direct sales to consumer brands, providing tailored biomolecules that enhance taste and nutrition. The company structures transactions through agreements with retailers, wholesalers, and direct-to-consumer brands, optimizing market distribution. Pricing plans align with the unique formulations of the biomolecules, enhancing product offerings while maintaining a commitment to sustainability and ethical practices.
In May 2026, StrainX Bioworks raised USD 13. 00 mn in venture funding, which will be utilized to enhance R&D, scale fermentation infrastructure, expand its team, and accelerate global commercialization. The company aims to develop and launch new products targeted at addressing specific market needs while planning to penetrate additional geographic regions, thereby broadening its market presence.
Current Investors
Prime Venture Partners, Leo Capital, Good Startup
Primary Industry
Biotechnology
Sub Industries
Beauty & Hygiene, Food, Biotechnology
Website
www.strainx.in/
Verticals
Clean Technology, Manufacturing
Company Stage
Series A
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.